Omnicell, Inc.(OMCL)Earnings, Financials & Key Ratios

OMCL•NASDAQ

$43.33

$1.97B mkt cap·978.1× P/E·Price updated May 7, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryHealthcare Communications, Workforce and Supply Chain

AboutOmnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.Show more

Revenue$1.18B+6.5%
EBITDA$84M-6.8%
Net Income$2M-83.6%
EPS (Diluted)0.04-83.6%
Gross Margin42.49%+0.3%
EBITDA Margin7.09%-12.5%
Operating Margin0.44%+1337.3%
Net Margin0.17%-84.6%
ROE0.17%-83.9%
ROIC0.31%+1490.3%
Debt/Equity0.17-46.1%
Interest Coverage2.84+3709.3%

Technical→

OMCL Key Insights

Omnicell, Inc. (OMCL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Profits declining 42.3% over 5 years
✗Thin 5Y average net margin of 1.4%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

OMCL Price & Volume

Omnicell, Inc. (OMCL) stock price & volume — 10-year historical chart

Loading chart...

OMCL Growth Metrics

Omnicell, Inc. (OMCL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years9.35%

5 Years5.84%

3 Years-2.94%

TTM7.86%

Profit CAGR

10 Years-23.72%

5 Years-42.34%

3 Years-28.64%

TTM-3.55%

EPS CAGR

10 Years-25.49%

5 Years-43.06%

3 Years-28.26%

TTM-3.51%

Return on Capital

10 Years2.39%

5 Years1.1%

3 Years-0.23%

Last Year0.34%

OMCL Recent Earnings

Omnicell, Inc. (OMCL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)

Q2 2026Latest

Apr 28, 2026

EPS

$0.55

Est $0.33

+66.7%

Revenue

$310M

Est $304M

+1.9%

Q1 2026

Feb 5, 2026

EPS

$0.40

Est $0.47

-14.9%

Revenue

$314M

Est $313M

+0.2%

Q4 2025

Oct 30, 2025

EPS

$0.51

Est $0.36

+41.7%

Revenue

$311M

Est $313M

-0.9%

Q3 2025

Jul 31, 2025

EPS

$0.45

Est $0.31

+45.2%

Revenue

$291M

Est $292M

-0.5%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 28, 2026	$0.55vs $0.33+66.7%	$310Mvs $304M+1.9%
Q1 2026	Feb 5, 2026	$0.40vs $0.47-14.9%	$314Mvs $313M+0.2%
Q4 2025	Oct 30, 2025	$0.51vs $0.36+41.7%	$311Mvs $313M-0.9%
Q3 2025	Jul 31, 2025	$0.45vs $0.31+45.2%	$291Mvs $292M-0.5%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
BDXBecton, Dickinson and CompanyDirect Competitor	55.53B	153.26	26.29	8.23%	5.33%	4.54%	0.76
HSICHenry Schein, Inc.Direct Competitor	8.09B	70.50	21.56	4.03%	3.02%	8.24%	0.77
MCKMcKesson CorporationProduct Competitor	92.15B	752.30	29.25	16.22%	1.18%	301.44%
CAHCardinal Health, Inc.Product Competitor	43.59B	185.22	28.72	-1.87%	0.62%
VEEVVeeva Systems Inc.Product Competitor	27.35B	168.23	30.92	16.34%	28.44%	13.41%	0.01
HCATHealth Catalyst, Inc.Product Competitor	112.89M	1.59	-0.62	1.48%	-57.2%	-54.67%	0.08
AMZNAmazon.com, Inc.Supply Chain	2.92T	271.17	37.82	12.38%	12.22%	23.34%	0.37
MSFTMicrosoft CorporationSupply Chain	3.13T	420.92	30.86	14.93%	39.34%	33.13%	0.33

Compare OMCL vs Peers

Omnicell, Inc. (OMCL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BDX

Most directly comparable listed peer for OMCL.

Scale Benchmark

vs MSFT

Larger-name benchmark to compare OMCL against a more recognizable public peer.

Peer Set

Compare Top 5

vs BDX, HSIC, MCK, CAH

OMCL Income Statement

Omnicell, Inc. (OMCL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	716.16M	787.31M	897.03M	892.21M	1.13B	1.3B	1.15B	1.11B	1.18B	1.23B
Revenue Growth %	3.4%	9.93%	13.94%	-0.54%	26.88%	14.48%	-11.48%	-3.04%	6.53%	7.86%
Cost of Goods Sold	394.08M	414.98M	460.12M	478.92M	577.37M	706.96M	647.18M	641.24M	681.4M	692.19M
COGS % of Revenue	55.03%	52.71%	51.29%	53.68%	51%	54.55%	56.42%	57.65%	57.51%	-
Gross Profit	322.09M▲ 0%	372.33M▲ 15.6%	436.91M▲ 17.3%	413.29M▼ 5.4%	554.65M▲ 34.2%	588.99M▲ 6.2%	499.93M▼ 15.1%	471M▼ 5.8%	503.44M▲ 6.9%	532.87M▲ 0%
Gross Margin %	44.97%	47.29%	48.71%	46.32%	49%	45.45%	43.58%	42.35%	42.49%	43.5%
Gross Profit Growth %	2.64%	15.6%	17.35%	-5.41%	34.2%	6.19%	-15.12%	-5.79%	6.89%	-
Operating Expenses	316.33M	327.94M	358.56M	377.77M	465.15M	591.31M	519.26M	470.67M	498.28M	499.24M
OpEx % of Revenue	44.17%	41.65%	39.97%	42.34%	41.09%	45.63%	45.27%	42.32%	42.05%	-
Selling, General & Admin	250.31M	263.1M	289.92M	307.61M	389.43M	486.34M	425.97M	380.25M	409.61M	409.57M
SG&A % of Revenue	34.95%	33.42%	32.32%	34.48%	34.4%	37.53%	37.13%	34.19%	34.57%	-
Research & Development	66.02M	64.84M	68.64M	70.16M	75.72M	104.97M	93.29M	90.41M	88.67M	89.67M
R&D % of Revenue	9.22%	8.24%	7.65%	7.86%	6.69%	8.1%	8.13%	8.13%	7.48%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income	5.75M▲ 0%	44.39M▲ 671.5%	78.35M▲ 76.5%	35.53M▼ 54.7%	89.51M▲ 151.9%	-2.32M▼ 102.6%	-19.33M▼ 732.1%	337K▲ 101.7%	5.16M▲ 1431.2%	33.63M▲ 0%
Operating Margin %	0.8%	5.64%	8.73%	3.98%	7.91%	-0.18%	-1.69%	0.03%	0.44%	2.75%
Operating Income Growth %	-11.22%	671.5%	76.5%	-54.66%	151.95%	-102.6%	-732.07%	101.74%	1431.16%	-
EBITDA	57.27M	95.74M	142.47M	107.12M	174.44M	96.85M	76.23M	90.09M	83.95M	111M
EBITDA Margin %	8%	12.16%	15.88%	12.01%	15.41%	7.47%	6.65%	8.1%	7.09%	9.06%
EBITDA Growth %	-11.69%	67.19%	48.81%	-24.81%	62.84%	-44.48%	-21.29%	18.19%	-6.81%	9.94%
D&A (Non-Cash Add-back)	51.51M	51.35M	64.12M	71.59M	84.93M	99.17M	95.56M	89.75M	78.8M	77.37M
EBIT	11.14M	44.39M	78.35M	35.53M	89.51M	-2.32M	-15.58M	337K	17.49M	39.45M
Net Interest Income	0	0	-5.8M	-2.1M	-22.39M	-130K	14.76M	20.38M	-6.17M	5.26M
Interest Income	0	0	0	0	0	0	14.76M	24.9M	0	7.3M
Interest Expense	0	0	5.8M	2.1M	22.39M	130K	0	4.53M	6.17M	2.14M
Other Income/Expense	-6.63M	-8.78M	-4.42M	-6.18M	-23.5M	-130K	-779K	25.26M	6.17M	4.13M
Pretax Income	-879K▲ 0%	35.62M▲ 4151.9%	73.93M▲ 107.6%	29.35M▼ 60.3%	66.01M▲ 124.9%	-2.45M▼ 103.7%	-20.11M▼ 719.7%	25.59M▲ 227.3%	11.32M▼ 55.7%	37.76M▲ 0%
Pretax Margin %	-0.12%	4.52%	8.24%	3.29%	5.83%	-0.19%	-1.75%	2.3%	0.96%	3.08%
Income Tax	-21.48M	-2.11M	12.6M	-2.85M	-11.84M	-8.1M	263K	13.06M	9.27M	17.33M
Effective Tax Rate %	2444.14%	-5.93%	17.04%	-9.69%	-17.94%	330.25%	-1.31%	51.04%	81.88%	45.89%
Net Income	20.61M▲ 0%	37.73M▲ 83.1%	61.34M▲ 62.6%	32.19M▼ 47.5%	77.85M▲ 141.8%	5.65M▼ 92.7%	-20.37M▼ 460.7%	12.53M▲ 161.5%	2.05M▼ 83.6%	20.43M▲ 0%
Net Margin %	2.88%	4.79%	6.84%	3.61%	6.88%	0.44%	-1.78%	1.13%	0.17%	1.67%
Net Income Growth %	3317.08%	83.11%	62.58%	-47.51%	141.81%	-92.74%	-460.68%	161.51%	-83.62%	-3.55%
Net Income (Continuing)	30.52M	37.73M	61.34M	32.19M	77.85M	5.65M	-20.37M	12.53M	2.05M	20.43M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.79▲ 0%	0.93▲ 17.7%	1.43▲ 53.8%	0.74▼ 48.3%	1.62▲ 118.9%	0.12▼ 92.6%	-0.45▼ 475.0%	0.27▲ 160.0%	0.04▼ 83.6%	0.44▲ 0%
EPS Growth %	203.85%	17.72%	53.76%	-48.25%	118.92%	-92.59%	-475%	160%	-83.59%	-3.51%
EPS (Basic)	0.81	0.96	1.48	0.76	1.79	0.13	-0.45	0.27	0.04	-
Diluted Shares Outstanding	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M	46.36M	45.94M
Basic Shares Outstanding	37.48M	39.24M	41.46M	42.58M	43.48M	44.4M	45.21M	46.05M	45.97M	45.32M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

OMCL Balance Sheet

Omnicell, Inc. (OMCL) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	367.12M	397.13M	483.24M	829.41M	780.7M	881.81M	927.57M	815.49M	680.07M	722.3M
Cash & Short-Term Investments	32.42M	67.19M	136.98M	496.17M	359.72M	341.85M	467.97M	381.68M	196.52M	239.22M
Cash Only	32.42M	67.19M	127.21M	485.93M	349.05M	330.36M	467.97M	369.2M	196.52M	239.22M
Short-Term Investments	0	0	9.77M	10.25M	10.66M	11.49M	0	12.47M	0	0
Accounts Receivable	198.81M	196.24M	218.36M	190.12M	240.89M	299.47M	263.89M	256.4M	216.86M	249.8M
Days Sales Outstanding	101.33	90.98	88.85	77.78	77.67	84.34	83.97	84.14	66.8	70.39
Inventory	96.14M	100.87M	108.01M	96.3M	119.92M	147.55M	110.1M	88.66M	100.91M	99.2M
Days Inventory Outstanding	89.04	88.72	85.68	73.39	75.81	76.18	62.09	50.47	54.05	54.49
Other Current Assets	4.5M	12.14M	1.06M	20.7M	31.01M	64.17M	51.36M	61.48M	132.08M	134.08M
Total Non-Current Assets	613.18M	684.11M	757.57M	995.09M	1.36B	1.33B	1.3B	1.31B	1.29B	1.28B
Property, Plant & Equipment	42.59M	51.5M	110.38M	114.19M	119.69M	132.01M	133.59M	138.3M	144.48M	144.45M
Fixed Asset Turnover	16.81x	15.29x	8.13x	7.81x	9.46x	9.82x	8.59x	8.04x	8.20x	8.42x
Goodwill	337.75M	335.89M	336.54M	499.31M	738.9M	734.27M	735.81M	734.73M	737.95M	737.29M
Intangible Assets	168.11M	143.69M	209.94M	262.24M	374.61M	323.67M	277.83M	246.7M	170.1M	165.43M
Long-Term Investments	15.44M	17.08M	19.75M	22.16M	18.39M	32.92M	54.8M	52.74M	60.74M	227.22M
Other Non-Current Assets	39.84M	120.76M	66.83M	82.18M	94.32M	83.74M	64.37M	75.53M	123.04M	380.02M
Total Assets	980.3M▲ 0%	1.08B▲ 10.3%	1.24B▲ 14.8%	1.82B▲ 47.0%	2.14B▲ 17.4%	2.21B▲ 3.2%	2.23B▲ 0.7%	2.12B▼ 4.8%	1.97B▼ 6.9%	2B▲ 0%
Asset Turnover	0.73x	0.73x	0.72x	0.49x	0.53x	0.59x	0.52x	0.52x	0.60x	0.61x
Asset Growth %	4.83%	10.3%	14.76%	47.04%	17.43%	3.19%	0.73%	-4.76%	-6.89%	-35.53%
Total Current Liabilities	212.54M	204.58M	237M	276.42M	876.16M	428.45M	367.79M	595.68M	476.61M	483.05M
Accounts Payable	48.29M	38.04M	46.38M	40.31M	71.51M	63.39M	45.03M	51.78M	43.99M	58.34M
Days Payables Outstanding	44.73	33.46	36.79	30.72	45.21	32.73	25.39	29.48	23.56	29.96
Short-Term Debt	15.21M	0	0	0	488.15M	0	0	174.32M	11.96M	0
Deferred Revenue (Current)	86.1M	81.83M	94.9M	125.2M	152.11M	187.21M	132.28M	201.98M	171.86M	784.44M
Other Current Liabilities	114.47M	124.88M	44.16M	55.75M	71.13M	73.45M	126.02M	0	191.63M	212.82M
Current Ratio	1.73x	1.94x	2.04x	3.00x	0.89x	2.06x	2.52x	1.37x	1.43x	1.43x
Quick Ratio	1.28x	1.45x	1.58x	2.65x	0.75x	1.71x	2.22x	1.22x	1.22x	1.22x
Cash Conversion Cycle	145.64	146.24	137.74	120.45	108.28	127.8	120.67	105.13	97.29	94.93
Total Non-Current Liabilities	250.57M	197.04M	158.56M	580.58M	119.65M	652.17M	670.13M	281.97M	266.3M	264.43M
Long-Term Debt	194.92M	135.42M	50M	467.2M	0	566.57M	569.66M	166.4M	167.6M	190.56M
Capital Lease Obligations	0	0	50.67M	48.9M	39.91M	39.41M	33.91M	31.12M	24.79M	105.81M
Deferred Tax Liabilities	28.58M	41.48M	39.09M	39.63M	51.7M	2.1M	1.62M	1.11M	683K	3.9M
Other Non-Current Liabilities	9.83M	9.56M	11.72M	19.17M	7.84M	6.72M	6.32M	7.22M	9.97M	36.33M
Total Liabilities	463.11M	401.63M	395.56M	857M	995.81M	1.08B	1.04B	877.65M	742.91M	747.48M
Total Debt	210.13M	135.42M	110.73M	528.29M	541.01M	616.74M	614.09M	382.55M	204.34M	190.56M
Net Debt	177.7M	68.22M	-16.48M	42.37M	191.96M	286.38M	146.12M	13.35M	7.83M	-48.66M
Debt / Equity	0.41x	0.20x	0.13x	0.55x	0.47x	0.55x	0.52x	0.31x	0.17x	0.17x
Debt / EBITDA	3.67x	1.41x	0.78x	4.93x	3.10x	6.37x	8.06x	4.25x	2.43x	1.72x
Net Debt / EBITDA	3.10x	0.71x	-0.12x	0.40x	1.10x	2.96x	1.92x	0.15x	0.09x	0.09x
Interest Coverage	-	-	13.50x	16.94x	4.00x	-17.87x	-	0.07x	2.84x	18.41x
Total Equity	517.2M▲ 0%	679.62M▲ 31.4%	845.25M▲ 24.4%	967.5M▲ 14.5%	1.15B▲ 18.5%	1.13B▼ 1.4%	1.19B▲ 5.2%	1.24B▲ 4.6%	1.23B▼ 0.9%	1.26B▲ 0%
Equity Growth %	19.83%	31.4%	24.37%	14.46%	18.52%	-1.44%	5.2%	4.57%	-0.92%	3.25%
Book Value per Share	13.36	16.76	19.68	22.12	23.92	24.63	26.30	26.88	26.57	27.35
Total Shareholders' Equity	517.2M	679.62M	845.25M	967.5M	1.15B	1.13B	1.19B	1.24B	1.23B	1.26B
Common Stock	48K	50K	51K	53K	54K	55K	56K	57K	58K	0
Retained Earnings	122.58M	197.45M	258.79M	290.72M	368.57M	390.73M	370.36M	382.89M	384.94M	0
Treasury Stock	-185.07M	-185.07M	-185.07M	-238.11M	-238.11M	-290.32M	-290.32M	-290.32M	-368.31M	0
Accumulated OCI	-6.11M	-10.85M	-9.45M	-5.52M	-8.41M	-17.09M	-13.43M	-17.2M	-8.85M	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

OMCL Cash Flow Statement

Omnicell, Inc. (OMCL) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	24.83M	103.97M	145.01M	185.87M	231.81M	77.78M	181.09M	187.72M	127.3M	127.3M
Operating CF Margin %	3.47%	13.21%	16.17%	20.83%	20.48%	6%	15.79%	16.88%	10.74%	-
Operating CF Growth %	-48.19%	318.64%	39.48%	28.18%	24.72%	-66.45%	132.83%	3.66%	-32.19%	61.2%
Net Income	20.61M	37.73M	61.34M	32.19M	77.85M	5.65M	-20.37M	12.53M	2.05M	20.43M
Depreciation & Amortization	51.51M	51.35M	64.12M	71.59M	106.98M	99.17M	95.56M	89.75M	86.63M	83.32M
Stock-Based Compensation	21.86M	28.89M	34.05M	44.7M	53.16M	68.25M	55.3M	39.32M	44.5M	31.24M
Deferred Taxes	-26.84M	-5.71M	-1.34M	-6.55M	0	-37.32M	-11.05M	-14.86M	-1.29M	6.77M
Other Non-Cash Items	2.11M	2.42M	2.65M	6.63M	50.42M	15.5M	17.98M	2.64M	3.74M	17.46M
Working Capital Changes	-44.41M	-10.72M	-15.81M	37.3M	-56.6M	-73.47M	43.67M	58.33M	-8.33M	-3.35M
Change in Receivables	-39.07M	-6.19M	-23.52M	12.03M	-40.97M	-60.36M	38.74M	-5M	41.42M	4.99M
Change in Inventory	-26.84M	-6.76M	-8.12M	12.36M	-25.7M	-30.11M	38.02M	5.39M	-11.22M	-7.04M
Change in Payables	19.71M	-9.15M	7.89M	-6.3M	0	-7.75M	-17.52M	7.21M	-9.28M	5.96M
Cash from Investing	-34.99M	-54.37M	-61.66M	-279.87M	-412.5M	-58.67M	-55.02M	-52.79M	-60.36M	-60.49M
Capital Expenditures	-30.54M	-54.37M	-61.66M	-54.87M	-28.97M	-60.74M	-55.02M	-36.46M	-40.41M	-52.53M
CapEx % of Revenue	4.26%	6.91%	6.87%	6.15%	2.56%	4.69%	4.8%	3.28%	3.41%	-
Acquisitions	-4.45M	0	0	-225M	-354.16M	2.07M	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-15.2M	1.68M	3.7M	-29.14M	-29.37M	15.35M	0	-5.93M	-9.78M	-9.6M
Cash from Financing	-9.88M	-13.6M	-23.48M	456.27M	47.36M	-20.95M	23.42M	-235.58M	-218.32M	-219.96M
Debt Issued (Net)	-43.5M	-77M	-90M	509.67M	0	0	-2.97M	-225.46M	-175M	-175M
Equity Issued (Net)	-5.89M	39.57M	37.81M	-61.77M	-16.29M	-52.21M	23.22M	38.58M	-60.73M	-61.24M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	-53.03M	-16.29M	-52.21M	0	0	-77.6M	-77.6M
Other Financing	39.52M	23.84M	28.71M	8.38M	63.65M	31.26M	3.17M	-48.7M	17.41M	16.27M
Net Change in Cash	-22.06M▲ 0%	34.77M▲ 257.6%	60.02M▲ 72.6%	362.71M▲ 504.3%	-134.3M▼ 137.0%	-2.79M▲ 97.9%	148.14M▲ 5419.4%	-102.36M▼ 169.1%	-147.58M▼ 44.2%	-123.44M▲ 0%
Free Cash Flow	-5.71M▲ 0%	49.59M▲ 969.0%	83.34M▲ 68.1%	131M▲ 57.2%	202.84M▲ 54.8%	17.04M▼ 91.6%	139.62M▲ 719.3%	151.26M▲ 8.3%	86.89M▼ 42.6%	111.77M▲ 0%
FCF Margin %	-0.8%	6.3%	9.29%	14.68%	17.92%	1.31%	12.17%	13.6%	7.33%	9.12%
FCF Growth %	-130.4%	968.97%	68.06%	57.18%	54.84%	-91.6%	719.32%	8.34%	-42.56%	-4.1%
FCF per Share	-0.15	1.22	1.94	2.99	4.23	0.37	3.09	3.27	1.87	1.87
FCF Conversion (FCF/Net Income)	1.21x	2.76x	2.36x	5.77x	2.98x	13.77x	-8.89x	14.98x	62.04x	5.47x
Interest Paid	6.55M	7.49M	3.58M	522K	1.92M	1.44M	0	1.62M	0	0
Taxes Paid	7.78M	3.49M	7.76M	10.34M	0	19M	0	11.28M	0	0

OMCL Key Ratios

Omnicell, Inc. (OMCL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	4.34%	6.3%	8.04%	3.55%	7.36%	0.5%	-1.76%	1.03%	0.17%	1.64%
Return on Invested Capital (ROIC)	0.65%	4.62%	7.45%	2.9%	5.72%	-0.13%	-1.05%	0.02%	0.31%	0.31%
Gross Margin	44.97%	47.29%	48.71%	46.32%	49%	45.45%	43.58%	42.35%	42.49%	43.5%
Net Margin	2.88%	4.79%	6.84%	3.61%	6.88%	0.44%	-1.78%	1.13%	0.17%	1.67%
Debt / Equity	0.41x	0.20x	0.13x	0.55x	0.47x	0.55x	0.52x	0.31x	0.17x	0.17x
Interest Coverage	-	-	13.50x	16.94x	4.00x	-17.87x	-	0.07x	2.84x	18.41x
FCF Conversion	1.21x	2.76x	2.36x	5.77x	2.98x	13.77x	-8.89x	14.98x	62.04x	5.47x
Revenue Growth	3.4%	9.93%	13.94%	-0.54%	26.88%	14.48%	-11.48%	-3.04%	6.53%	7.86%

OMCL SEC Filings & Documents

Omnicell, Inc. (OMCL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 28, 2026·SEC

Material company update

Feb 5, 2026·SEC

Material company update

Dec 8, 2025·SEC

10-K Annual Reports

FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 28, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 7, 2025·SEC

OMCL Frequently Asked Questions

Omnicell, Inc. (OMCL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Omnicell, Inc. (OMCL) reported $1.23B in revenue for fiscal year 2025. This represents a 1719% increase from $67.4M in 2000.

Omnicell, Inc. (OMCL) grew revenue by 6.5% over the past year. This is steady growth.

Yes, Omnicell, Inc. (OMCL) is profitable, generating $20.4M in net income for fiscal year 2025 (0.2% net margin).

Dividend & Returns

Omnicell, Inc. (OMCL) has a return on equity (ROE) of 0.2%. This is below average, suggesting room for improvement.

Omnicell, Inc. (OMCL) generated $111.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More OMCL

Omnicell, Inc. (OMCL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Omnicell, Inc.(OMCL)Earnings, Financials & Key Ratios

OMCL Key Insights

✓Strengths

✗Weaknesses

OMCL Price & Volume

OMCL Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

OMCL Recent Earnings

OMCL Peer Comparison

Compare OMCL vs Peers

vs BDX

vs MSFT

Compare Top 5

OMCL Income Statement

OMCL Balance Sheet

OMCL Cash Flow Statement

OMCL Key Ratios

OMCL SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

OMCL Frequently Asked Questions

Explore More OMCL

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation